Enterprise Value
$2.45 B
-$28.15 M-1.13%
0 min ago
Summary
- As of February 26, 2025, BCRX enterprise value is $2.45 billion, with a fall of -$28.15 million (-1.13%) during the most recent trading day.
- Over the past year, BCRX enterprise value has increased by +$560.99 million (+29.62%).
- BCRX enterprise value is now -34.33% below its all-time high of $3.74 billion.
Performance
BCRX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
BCRX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -1.1% | -1.6% | -1.6% |
| 1 m1 month | +6.4% | +9.2% | +9.2% |
| 3 m3 months | +8.5% | +12.5% | +11.7% |
| 6 m6 months | +1.4% | +3.9% | +3.0% |
| ytdytd | +7.6% | +11.1% | +11.1% |
| 1 y1 year | +29.6% | +47.8% | +46.1% |
| 5 y5 years | +580.7% | +346.6% | +230.2% |
BCRX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.6% | $2.30 B | +6.8% | |
| 3 m | 3-month | $2.69 B | -8.6% | $2.19 B | +12.1% |
| 6 m | 6-month | $2.69 B | -8.6% | $2.17 B | +13.3% |
| 1 y | 1-year | $2.69 B | -8.6% | $1.60 B | +53.7% |
| 3 y | 3-year | $3.54 B | -30.6% | $1.60 B | +53.7% |
| 5 y | 5-year | $3.74 B | -34.3% | $217 M | +1030.2% |
| alltime | all time | $3.74 B | -34.3% | -$5 M | >+9999.0% |
BioCryst Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $2.45 B(+7.6%) |
| 2024 | $2.28 B(+17.0%) |
| 2023 | $1.95 B(-24.0%) |
| 2022 | $2.57 B(-2.9%) |
| 2021 | $2.64 B(+99.4%) |
| 2020 | $1.33 B(+163.9%) |
| 2019 | $502.06 M(-45.6%) |
| 2018 | $923.30 M(+89.3%) |
| 2017 | $487.64 M(-2.2%) |
| 2016 | $498.66 M(-34.2%) |
| 2015 | $758.30 M(-10.8%) |
| 2014 | $850.43 M(+85.7%) |
| 2013 | $457.94 M(+462.7%) |
| 2012 | $81.38 M(-35.6%) |
| 2011 | $126.34 M(-42.3%) |
| 2010 | $218.82 M(-9.8%) |
| Date | Value |
|---|---|
| 2009 | $242.51 M(+706.5%) |
| 2008 | $30.07 M(-85.2%) |
| 2007 | $203.48 M(-39.0%) |
| 2006 | $333.70 M(-26.4%) |
| 2005 | $453.47 M(+287.8%) |
| 2004 | $116.92 M(+2.5%) |
| 2003 | $114.07 M(+3548.1%) |
| 2002 | $3.13 M(-93.9%) |
| 2001 | $50.86 M(-52.8%) |
| 2000 | $107.74 M(-78.5%) |
| 1999 | $500.69 M(+441.8%) |
| 1998 | $92.42 M(-0.7%) |
| 1997 | $93.03 M(-57.9%) |
| 1996 | $221.00 M(+168.2%) |
| 1995 | $82.41 M(+137.0%) |
| 1994 | $34.77 M |
FAQ
- What is BioCryst Pharmaceuticals enterprise value?
- What is the all time high enterprise value for BioCryst Pharmaceuticals?
- What is BCRX enterprise value year-to-date change?
- What is BioCryst Pharmaceuticals enterprise value year-on-year change?
What is BioCryst Pharmaceuticals enterprise value?
The current enterprise value of BCRX is $2.45 B
What is the all time high enterprise value for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high enterprise value is $3.74 B
What is BCRX enterprise value year-to-date change?
BioCryst Pharmaceuticals enterprise value has changed by +$174.13 M (+7.64%) since the beginning of the year
What is BioCryst Pharmaceuticals enterprise value year-on-year change?
Over the past year, BCRX enterprise value has changed by +$560.99 M (+29.62%)